Live
CellGenomic atlas of <em>Bifidobacterium infantis</em> and <em>B. longum</em> informs infant probiotic designFierceBiotechGenentech antibody fails to boost muscle in rare diseases, raising questions for obesity trialIlluminaIllumina and Labcorp Expand Precision Oncology Testing Partnership - OncodailyLonza NewsLonza Group AG stock under pressure on Swiss Exchange amid trade surplus data and CDMO pivot - AD HOC NEWSEndpoints NewsFDA seeks input on Makary's voucher pilotBioPharma DiveEarendil Labs, an AI-powered drugmaker, hauls in $787MBioWorldBiopharma money raised: Jan. 1-March 20, 2026BioWorldMoney raised by biopharmaEndpoints NewsTop HHS official tamps down expectations on scope of TrumpRxFierceBiotechChutes & Ladders—Eric Topol boards Flagship as advisorFierceBiotechBehind the curtain: What Xaira is building after its $1B fundraiseFierceBiotechIntuitive recalls surgical stapler reloads following patient death
Cell Mar 20, 2026

Genomic atlas of <em>Bifidobacterium infantis</em> and <em>B. longum</em> informs infant probiotic design

Genomic atlas of Bifidobacterium infantis and B. longum informs infant probiotic design

Original
Body unavailable. Use the original source.

Directory

59 All